We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Lithium Found to Protect Brain Cells During Cranial Radiation

By MedImaging International staff writers
Posted on 27 Apr 2009
Cranial radiation therapy to treat brain cancer can result in various long-term neurologic side effects, especially in children. Lithium has protective properties in the brain that make it a potential therapy for reducing these side effects; however, little is known about the mechanisms by which it protects nerves. In a new study, researchers presented findings generated in irradiated mice that lithium protects nerves in the region of the brain known as the hippocampus by promoting DNA repair.

Specifically, a decreased number of double-strand DNA breaks were observed in lithium-treated, irradiated mice and brain cells compared to the control mice. This decrease was associated with increased markers for the nonhomologous end-joining DNA repair pathway. When this pathway was blocked in mice, lithium provided considerably less protection to the hippocampal nerve cells.

The investigators, led by Dr. Fen Xia and colleagues from Vanderbilt University Medical Center (Nashville, TX, USA), therefore, concluded that lithium should be considered as a possible treatment to reduce the long-term neurologic side effects of cranial radiation therapy, particularly in children, and that targeted therapies to enhance DNA repair may provide an avenue for future therapeutic development.

The study was published in the April 1, 2009, issue of the Journal of Clinical Investigation (JCI).

Related Links:

Vanderbilt University Medical Center



40/80-Slice CT System
uCT 528
Ultrasonic Pocket Doppler
SD1
Biopsy Software
Affirm® Contrast
Post-Processing Imaging System
DynaCAD Prostate

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.